These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3867402)

  • 1. Phase II trial of epirubicin in gastric cancer.
    Scarffe JH; Kenny JB; Johnson RJ; Owens SE; Giles GR; Leveson SH; Maley WV
    Cancer Treat Rep; 1985 Nov; 69(11):1275-7. PubMed ID: 3867402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K; Suga S; Kano H; Sakakibara K; Hayashi T; Nakai T; Nagano I; Yokoyama Y; Morise K; Hayakawa M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
    Sakata Y; Yoshida Y
    Gan To Kagaku Ryoho; 1986 May; 13(5):1887-92. PubMed ID: 3458431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of paclitaxel and epirubicin in advanced breast cancer.
    Rischin D; Smith J; Millward M; Lewis C; Boyer M; Richardson G; Toner G; Gurney H; McKendrick J
    Br J Cancer; 2000 Aug; 83(4):438-42. PubMed ID: 10945487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase II study of SM-5887 for advanced gastric cancer].
    Tsushima K; Sakata Y; Munakata A; Sato T; Chiba Y; Nara H; Kawazu S; Matsukawa M; Ohmi T; Aizawa T
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1151-4. PubMed ID: 1647150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase II study of epirubicin in malignant lymphoma].
    Masaoka T; Shibata H; Sampi K; Hirota Y; Yoshida Y; Chiba Y; Shirakawa S; Kobayashi T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of 4'-epi-doxorubicin in locally advanced or metastatic gastric cancer.
    Cazap E; Estevez R; Bruno M; Levy D; Algamiz C; Chacon R; Badano C; Romero A; Desimone G; Roca E
    Tumori; 1988 Jun; 74(3):313-5. PubMed ID: 3165228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
    Zhang CX; Huang S; Xu N; Fang JW; Shen P; Bao YH; Mou BH; Shi MG; Zhong XL; Xiong PJ
    Anticancer Drugs; 2007 Jun; 18(5):581-6. PubMed ID: 17414627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
    Magee MJ; Howard J; Bosl GJ; Wittes RE
    Cancer Treat Rep; 1985 Jan; 69(1):125-6. PubMed ID: 3855384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A phase I trial of 4'-epiadriamycin].
    Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma.
    Eatock MM; Anthony DA; El-Abassi M; Wilson P; Paul J; Smith M; Soukop M; Evans TR
    Br J Cancer; 2000 Jun; 82(12):1925-31. PubMed ID: 10864199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.
    Kulke MH; Wu B; Clark JW; Enzinger PC; Lynch TJ; Vincitore M; Michelini A; Fuchs CS
    Cancer Invest; 2006; 24(3):229-34. PubMed ID: 16809148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H; Ogawa M; Miyamoto H; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.
    Ajani JA; Kelsen DP; Haller D; Hargraves K; Healey D
    Cancer J; 2000; 6(2):78-81. PubMed ID: 11069223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of (2" R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with advanced or recurrent gastric cancer. Clinical study group of THP for gastric cancer in Japan].
    Nakao I; Wakui A; Hattori T; Sugimachi K; Saito T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1325-32. PubMed ID: 2069402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
    Içli F; Celik I; Aykan F; Uner A; Demirkazik A; Ozet A; Ozgüroğlu M; Taş F; Akbulut H; Firat D
    Cancer; 1998 Dec; 83(12):2475-80. PubMed ID: 9874451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.